Excessive inflammatory and metabolic responses to acute SARS-CoV-2 infection are associated with a distinct gut microbiota composition
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and associated clinical sequelae requires well-coordinated metabolic and immune responses that limit viral spread and promote recovery of damaged systems. In order to understand potential mechanisms and interactions that influence coronavirus disease 2019 (COVID-19) outcomes, we performed a multi-omics analysis on hospitalised COVID-19 patients and compared those with the most severe outcome (i.e. death) to those with severe non-fatal disease, or mild/moderate disease, that recovered. A distinct subset of 8 cytokines and 140 metabolites in sera identified those with a fatal outcome to infection. In addition, elevated levels of multiple pathobionts and lower levels of protective or anti-inflammatory microbes were observed in the faecal microbiome of those with the poorest clinical outcomes. Weighted gene correlation network analysis (WGCNA) identified modules that associated severity-associated cytokines with tryptophan metabolism, coagulation-linked fibrinopeptides, and bile acids with multiple pathobionts. In contrast, less severe clinical outcomes associated with clusters of anti-inflammatory microbes such as Bifidobacterium or Ruminococcus , short chain fatty acids (SCFAs) and IL-17A. Our study uncovered distinct mechanistic modules that link host and microbiome processes with fatal outcomes to SARS-CoV-2 infection. These features may be useful to identify at risk individuals, but also highlight a role for the microbiome in modifying hyperinflammatory responses to SARS-CoV-2 and other infectious agents.
Article activity feed
-
SciScore for 10.1101/2021.10.26.465865: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: All patients or patient representatives signed a patient informed consent.
IRB: The study was approved by local ethics committees (EKOS 20/058 for the three Swiss sites and The Clinical Research Ethics Committee of the Cork Teaching Hospitals for Cork University Hospital).Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources The mediators measured included IL-1α, IL-1β, IL-1RA, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17B, IL-17C, IL-21, IL-22, … SciScore for 10.1101/2021.10.26.465865: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Consent: All patients or patient representatives signed a patient informed consent.
IRB: The study was approved by local ethics committees (EKOS 20/058 for the three Swiss sites and The Clinical Research Ethics Committee of the Cork Teaching Hospitals for Cork University Hospital).Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources The mediators measured included IL-1α, IL-1β, IL-1RA, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12/23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, IL-17A/F, IL-17B, IL-17C, IL-21, IL-22, IL-23, IL-27, IL-31, TNF-α, TNF-β, IFN-γ, IP-10, MIP-1α, MIP-1β, MIP-3α, MCP-1, MCP-4, Eotaxin, Eotaxin-3, TARC, MDC, TSLP, CRP, SAA, VEGF-A, VEGF-C, VEGF-D, sTie-2, Flt-1, sICAM-1, sVCAM-1, bFGF, PIGF and GM-CSF. Metabolomics: Untargeted metabolomics on patient sera was performed by MetabolonTM using the HD4 platform. MCP-1suggested: NoneSoftware and Algorithms Sentences Resources Pairwise differential abundance analysis was performed between conditions using R package LIMMA. LIMMAsuggested: (LIMMA, RRID:SCR_010943)Python 3 gseapy package was used to perform a hypergeometric test between list of significant metabolites and reference. Pythonsuggested: (IPython, RRID:SCR_001658)Importance plots, dot plots, bar plots, pca plots were produced with R package ggplot2. ggplot2suggested: (ggplot2, RRID:SCR_014601)Heatmaps were designed with the R package ComplexeHeatmap. ComplexeHeatmapsuggested: NoneNetworks were represented using Cytoscape 3.6.1 and metabolites of interest highlighted. Cytoscapesuggested: (Cytoscape, RRID:SCR_003032)For the microbiome analysis, the raw Illumina reads obtained for each sample were quality-filtered using the trimmomatic program, using the default parameters47. trimmomaticsuggested: (Trimmomatic, RRID:SCR_011848)Estimates of alpha diversity were computed using the diversity function of the vegan package of R. vegansuggested: (vegan, RRID:SCR_011950)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-
